Image
Friday, May 3, 2024
In a study published in Neuron, four new genetic risk factors for multiple system atrophy (MSA) were identified through a comprehensive look at the entire genomes of people with the disorder.
Image
Thursday, May 2, 2024
TIME has named Avindra Nath, M.D., senior investigator and clinical director of the National Institute of Neurological Disorders and Stroke (NINDS), to the inaugural 2024 TIME 100 Health, a new annual list of 100 individuals who most influenced global health.
Image
Friday, April 26, 2024
Today, the National Institute of Neurological Disorders and Stroke (NINDS) announced the selection of Michelle Jones-London, Ph.D., as the Institute’s first Associate Director for Programs to Enhance the Neuroscience Workforce.
Image
Friday, April 19, 2024
Dr. Reich is recognized for his achievements in developing new MRI methodologies
Image
Friday, March 1, 2024
The National Institutes of Health Stroke Scale (NIHSS), or NIH Stroke Scale, is the most widely used tool for health professionals to assess the severity of a stroke. Developed more than 30 years ago, the NIH Stroke Scale has recently been updated with new visual stimuli and is available for download.
Image
Tuesday, February 20, 2024
The National Institutes of Health (NIH) has selected 10 recipients of the NIH Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) in Biomedical and Behavioral Research Prize. Among the awardees—each receiving $100,000—is the University of Puerto Rico-Rio Piedras (UPR-RP) in recognition of their Neuroscience Research Opportunities to Increase Diversity (NeuroID) program.
Image
Monday, December 11, 2023
Team science expands our ability to pursue some of the most challenging problems in neuroscience in a comprehensive, multidisciplinary, and mechanistic manner. The National Institute of Neurological Disorders and Stroke (NINDS) announces the first round of awards for the new NINDS Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) program.
Image
Tuesday, October 31, 2023
ReveraGen BioPharma, a company supported by a small business grant from the National Institute of Neurological Disorders and Stroke (NINDS), has developed a new drug for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease.
Image
Thursday, October 5, 2023
The National Institutes of Health is committed to advancing research on amyotrophic lateral sclerosis (ALS).
Image
Tuesday, September 26, 2023
In the human brain, 86 billion neurons form more than 100 trillion connections with other neurons at junctions called synapses. Scientists are now working on an ambitious effort to develop technologies to map these connections across the brain, from mice to humans.